Valion Bio Return on Equity

Valion Bio (VBIO) currently reports a ROE of -232.5%. That is below the sector sector average of 11.73%. Use the charts on this page to explore Valion Bio's ROE history and peer comparisons.

Valion Bio's ROE of -232.5% is lower than the its sector sector average of 11.73%. That is roughly 2081.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Valion Bio's current -232.5% should be judged against industry norms (sector average: 11.73%) and against VBIO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -232.5%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.73%. From there, open related valuation or income-statement pages for Valion Bio, and consider following VBIO for alerts when major investors trade the stock.